Is it sufficient to evaluate COVID-19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?

Yildirim, Fatma; Yildirim, Mehmet

Yildirim, Fatma; Yildirim, Mehmet.

Yildirim F; Department of Pulmonary Diseases, COVID Intensive Care Unit, University of Health Sciences, Diskapi Yildirim Beyazit Research and Education Hospital, Ankara, Turkey.
Yildirim M; Department of Internal Medicine, COVID Intensive Care Unit, University of Health Sciences, Diskapi Yildirim Beyazit Research and Education Hospital, Ankara, Turkey.

Clin Respir J ; 16(7): 533-534, 2022 07.

Article in English | MEDLINE | ID: covidwho-1916103

Subject(s)

COVID-19; Venous Thromboembolism; Anticoagulants; Critical Illness; Humans; Retrospective Studies; Risk Factors; Severity of Illness Index; Venous Thromboembolism/diagnosis; Venous Thromboembolism/epidemiology; Venous Thromboembolism/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Clin Respir J Year: 2022 Document Type: Article Affiliation country: Crj.13520

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google